227 related articles for article (PubMed ID: 28872058)
1. Nanoparticles target early-stage breast cancer metastasis in vivo.
Goldman E; Zinger A; da Silva D; Yaari Z; Kajal A; Vardi-Oknin D; Goldfeder M; Schroeder JE; Shainsky-Roitman J; Hershkovitz D; Schroeder A
Nanotechnology; 2017 Oct; 28(43):43LT01. PubMed ID: 28872058
[TBL] [Abstract][Full Text] [Related]
2. Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice.
Fricke IB; De Souza R; Costa Ayub L; Francia G; Kerbel R; Jaffray DA; Zheng J
PLoS One; 2018; 13(5):e0196892. PubMed ID: 29723251
[TBL] [Abstract][Full Text] [Related]
3. Spatiotemporal Targeting of a Dual-Ligand Nanoparticle to Cancer Metastasis.
Doolittle E; Peiris PM; Doron G; Goldberg A; Tucci S; Rao S; Shah S; Sylvestre M; Govender P; Turan O; Lee Z; Schiemann WP; Karathanasis E
ACS Nano; 2015 Aug; 9(8):8012-21. PubMed ID: 26203676
[TBL] [Abstract][Full Text] [Related]
4. Liposomal Nanoparticles Carrying anti-IL6R Antibody to the Tumour Microenvironment Inhibit Metastasis in Two Molecular Subtypes of Breast Cancer Mouse Models.
Guo C; Chen Y; Gao W; Chang A; Ye Y; Shen W; Luo Y; Yang S; Sun P; Xiang R; Li N
Theranostics; 2017; 7(3):775-788. PubMed ID: 28255366
[TBL] [Abstract][Full Text] [Related]
5. In vivo magnetic resonance imaging investigating the development of experimental brain metastases due to triple negative breast cancer.
Hamilton AM; Foster PJ
Clin Exp Metastasis; 2017 Feb; 34(2):133-140. PubMed ID: 28108861
[TBL] [Abstract][Full Text] [Related]
6. Imaging Early-Stage Metastases Using an
Mason CA; Carter LM; Mandleywala K; de Souza Franca PD; Meyer JP; Mamun T; Backer JM; Backer MV; Reiner T; Lewis JS
Mol Imaging Biol; 2021 Jun; 23(3):340-349. PubMed ID: 33156495
[TBL] [Abstract][Full Text] [Related]
7. Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer.
Moase EH; Qi W; Ishida T; Gabos Z; Longenecker BM; Zimmermann GL; Ding L; Krantz M; Allen TM
Biochim Biophys Acta; 2001 Feb; 1510(1-2):43-55. PubMed ID: 11342146
[TBL] [Abstract][Full Text] [Related]
8. LyP-1 Conjugated Nanoparticles for Magnetic Resonance Imaging of Triple Negative Breast Cancer.
Abulrob A; Corluka S; Blasiak B; Gino Fallone B; Ponjevic D; Matyas J; Tomanek B
Mol Imaging Biol; 2018 Jun; 20(3):428-435. PubMed ID: 29101636
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of metastatic tumor growth and metastasis via targeting metastatic breast cancer by chlorotoxin-modified liposomes.
Qin C; He B; Dai W; Zhang H; Wang X; Wang J; Zhang X; Wang G; Yin L; Zhang Q
Mol Pharm; 2014 Oct; 11(10):3233-41. PubMed ID: 24559485
[TBL] [Abstract][Full Text] [Related]
10. Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer.
Cao H; Dan Z; He X; Zhang Z; Yu H; Yin Q; Li Y
ACS Nano; 2016 Aug; 10(8):7738-48. PubMed ID: 27454827
[TBL] [Abstract][Full Text] [Related]
11. Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
Zhang T; Prasad P; Cai P; He C; Shan D; Rauth AM; Wu XY
Acta Pharmacol Sin; 2017 Jun; 38(6):835-847. PubMed ID: 28216624
[TBL] [Abstract][Full Text] [Related]
12. Therapy targeted to the metastatic niche is effective in a model of stage IV breast cancer.
Yoo B; Kavishwar A; Wang P; Ross A; Pantazopoulos P; Dudley M; Moore A; Medarova Z
Sci Rep; 2017 Mar; 7():45060. PubMed ID: 28322342
[TBL] [Abstract][Full Text] [Related]
13. Thermosensitive liposome formulated indocyanine green for near-infrared triggered photodynamic therapy: in vivo evaluation for triple-negative breast cancer.
Shemesh CS; Moshkelani D; Zhang H
Pharm Res; 2015 May; 32(5):1604-14. PubMed ID: 25407543
[TBL] [Abstract][Full Text] [Related]
14. Treating metastatic triple negative breast cancer with CD44/neuropilin dual molecular targets of multifunctional nanoparticles.
Liang DS; Zhang WJ; Wang AT; Su HT; Zhong HJ; Qi XR
Biomaterials; 2017 Aug; 137():23-36. PubMed ID: 28528300
[TBL] [Abstract][Full Text] [Related]
15. Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA.
Mikhaylova M; Stasinopoulos I; Kato Y; Artemov D; Bhujwalla ZM
Cancer Gene Ther; 2009 Mar; 16(3):217-26. PubMed ID: 18927599
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
[TBL] [Abstract][Full Text] [Related]
17. Surgically-Induced Multi-organ Metastasis in an Orthotopic Syngeneic Imageable Model of 4T1 Murine Breast Cancer.
Zhang Y; Zhang N; Hoffman RM; Zhao M
Anticancer Res; 2015 Sep; 35(9):4641-6. PubMed ID: 26254353
[TBL] [Abstract][Full Text] [Related]
18. Characterization of organ-specific immunoliposomes for delivery of 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine in a mouse lung-metastasis model.
Mori A; Kennel SJ; van Borssum Waalkes M; Scherphof GL; Huang L
Cancer Chemother Pharmacol; 1995; 35(6):447-56. PubMed ID: 7882453
[TBL] [Abstract][Full Text] [Related]
19. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
20. Hydrophobic interaction mediating self-assembled nanoparticles of succinobucol suppress lung metastasis of breast cancer by inhibition of VCAM-1 expression.
Cao H; Zhang Z; Zhao S; He X; Yu H; Yin Q; Zhang Z; Gu W; Chen L; Li Y
J Control Release; 2015 May; 205():162-71. PubMed ID: 25598420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
